Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis

NCT03992417 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT03992417
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03992417 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis
Lead sponsor
Sanofi
Phase
Observational
Overall status
Active, not recruiting
Start date
June 11, 2019
Completion date
March 31, 2027
Enrollment
955 (actual)
Sites
105

Conditions

As the registry lists them; a condition with its own page is linked.

dermatitis atopic